Stallergenes gets European approval for dust mite allergy tablet
Stallergenes Greer, which is based in France, will compete with ALK within the indication.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY CATHERINE BRETT
ALK's archrival, Stallergenes Greer, is closing in on the lucrative allergy pill market, which ALK has called one of the most important future growth markets.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
